Association of AGTR1 and ACACB Gene Polymorphism and Diabetic Nephropathy in Type 2 Diabetes
|ClinicalTrials.gov Identifier: NCT01069549|
Recruitment Status : Completed
First Posted : February 17, 2010
Last Update Posted : October 26, 2015
|Condition or disease|
|Diabetes Mellitus, Type 2|
|Study Type :||Observational|
|Actual Enrollment :||476 participants|
|Observational Model:||Case Control|
|Official Title:||Study of the Association of AGTR1 and ACACB Gene Polymorphism and Susceptibility of Diabetic Nephropathy in North Indian Type 2 Diabetic Patients|
|Study Start Date :||November 2009|
|Actual Primary Completion Date :||April 2011|
|Actual Study Completion Date :||May 2011|
subjects with diabetic nephropathy.
Subjects with Type 2 Diabetes. Duration of diabetes should be more than or equal to 5 years. Age between 30 and 85 years. Diabetic nephropathy as defined by ADA.
Subject must be of north Indian origin.
Type 1 diabetes and kidney disease other than diabetes nephropathy are excluded form the study.
Subjects without Diabetic nephropathy.
This group of subject with similar characteristics as group 1 without any evidence of nephropathy.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01069549
|Postgraduate Institute of Medical Education & Research|
|Chandigarh, India, 1610012|
|Study Chair:||anil Bhansali, DM||Postgradute Institute of Medical Education & Research|